Investor Relations
Nov 09, 2018
OPKO Health Reports Third Quarter 2018 Financial Results MORE >>
Nov 08, 2018
BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services MORE >>
Nov 08, 2018
OPKO Health to Announce Third Quarter 2018 Financial Results on November 9, 2018 MORE >>
Sep 14, 2018
OPKO Confirms Resumption of Common Stock Trading on Nasdaq MORE >>

Corporate Governance

The Board of Directors of OPKO Health, Inc. (the "Company") sets high standards for the Company's employees, officers, and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business.

Communications with the Board

Stockholders and all interested parties may initiate in writing any communication with our Board of Directors, the presiding member of the non-management directors, or any individual director by sending the correspondence to OPKO Health, Inc., 4400 Biscayne Blvd., Miami, Florida 33137, Attention: Secretary. This centralized process assists our Board of Directors in reviewing and responding to communications in an appropriate manner. If a stockholder or any interested party would like the letter to be forwarded directly to one of the Chairmen of the three standing committees of the Board, he or she should so indicate. If no specific direction is indicated, the Secretary's office will review the letter and forward it to the appropriate Board member(s).